Different Hemostatic Agents Used in Partial Pulpotomy on Pulp Survival and Postoperative Pain
Launched by CUKUROVA UNIVERSITY · Jun 30, 2025
Trial Information
Current as of July 14, 2025
Not yet recruiting
Keywords
ClinConnect Summary
This clinical trial is studying how well three different liquids—sodium hypochlorite (a common disinfectant), chlorhexidine (an antiseptic), and cold saline (saltwater)—work to stop bleeding during a dental procedure called partial pulpotomy. This procedure is done when a tooth’s inner tissue (called the pulp) is exposed due to a cavity but is still healthy enough to save. The study will look at how much pain patients feel after the treatment, and whether the pulp stays healthy over time, checking at several points from a few days up to one year.
People who might join this study are those with permanent teeth that have a cavity exposing the pulp but don’t have ongoing, spontaneous tooth pain. Their tooth should still be alive and healthy based on simple tests and X-rays. People with health conditions that affect healing, pregnant women, or those whose tooth pulp is already dead won’t be eligible. If you participate, you can expect to have the partial pulpotomy done using one of the three liquids to control bleeding, then you’ll be asked about any pain you experience afterward. Your tooth will also be monitored for up to a year to see how well it heals. This study hasn’t started enrolling participants yet.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Permanent teeth with carious pulp exposure (no spontaneous pain). Positive vitality test (Endo-Ice). No periapical radiolucency.
- Exclusion Criteria:
- • Systemic diseases affecting healing. Pregnancy. Non-vital pulp/necrosis
About Cukurova University
Cukurova University, a prominent institution located in Adana, Turkey, is dedicated to advancing medical research and improving healthcare outcomes through innovative clinical trials. With a strong emphasis on interdisciplinary collaboration, the university fosters a dynamic research environment that promotes the development of new therapies and treatment modalities. Its commitment to ethical standards and patient safety ensures that all clinical trials are conducted with the highest level of scientific rigor. Cukurova University aims to contribute significantly to the global medical community by facilitating groundbreaking studies that address pressing health challenges.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Patients applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported